Community Healthcare Trust Incorporated (NYSE:CHCT) released its third-quarter 2026 earnings results on November 3, 2026, reporting net income of approximately $3.1 million and FFO of $0.54 per diluted common share for the three months ended September 30, 2026.

Key Highlights

  • Net income: Approximately $3.1 million, or $0.09 per diluted common share, for the three months ended September 30, 2026.
  • FFO and AFFO: $0.54 and $0.58 per diluted common share, respectively, for Q3 2026; FFO per share rose $0.04, or 8.0%, year over year.
  • Quarterly dividend: $0.33 per common share declared November 3, 2026, payable November 25, 2026, to stockholders of record as of November 13, 2026.
  • Capital recycling: Since the close of Q2 2026, the company completed $32.3 million in property dispositions; subsequent to September 30, 2026, two additional properties were sold for net proceeds of approximately $31.5 million.
  • Leased occupancy: Grew from 89.8% in Q2 2026 to 90.1% in Q3 2026, with total revenue increasing $1.2 million, or 4%, quarter over quarter.
  • Pipeline: Four properties under definitive purchase agreements at an aggregate expected purchase price of approximately $99.0 million, with expected returns of approximately 9.1% to 9.75%.
  • Portfolio size: As of September 30, 2026, the company held approximately $1.2 billion in investments across 196 real estate properties in 36 states, totaling approximately 4.5 million square feet.

Community Healthcare Trust Reports Q3 2026 Operating and Strategic Progress

According to the filing, Community Healthcare Trust's Q3 2026 results reflected progress under its Strategic Plan announced August 4, 2026. The company reported total revenue growth of $1.2 million, or 4%, from Q2 2026 to Q3 2026, alongside a $0.7 million, or 14.3%, decline in general and administrative expenses over the same period. On a year-over-year basis, the company disclosed that AFFO per diluted share increased $0.02, or 3.6%.

The filing noted that net income and FFO for Q3 2026 were affected by a reduction in deferred compensation expense of approximately $0.9 million compared to Q2 2026. The company attributed this decrease primarily to restricted stock awards and performance-based restricted stock units that were fully amortized or forfeited at June 30, 2026, totaling approximately $1.25 million, partially offset by approximately $0.4 million in new amortization from restricted stock awards and units granted during Q3 2026.

The filing also disclosed that a geriatric behavioral hospital tenant occupying six of the company's properties paid approximately $0.5 million in rent during Q3 2026, an increase of approximately $0.2 million from Q2 2026. The company stated that the tenant previously signed a Letter of Intent in July 2025 to sell its business to a behavioral healthcare provider, with the prospective buyer finalizing due diligence and drafting definitive purchase agreements. The company stated it "cannot provide assurance regarding the specific timing or the ultimate certainty of the closing." During Q3 2026, the company also sold one property, received net proceeds of approximately $0.1 million, and recorded a $0.7 million loss on that sale. The company did not issue any shares under its ATM program during the quarter.

What Was Disclosed

The filing disclosed Q3 2026 financial results including net income, FFO, and AFFO per share; a $0.33 quarterly dividend declaration; $32.3 million in completed dispositions since Q2 2026 close; and four properties under agreement at an aggregate expected purchase price of approximately $99.0 million.